News

News

Aragen Launches First Phase of Biologics Facility in India

28.03.2024 -

Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen...

News

Syensqo Inaugurates Application Development Labs in Italy

28.03.2024 -

Syensqo has opened its application development labs (ADL) in Bollate, Italy. The project includes an expansion of 1,300 m2 in a new building and represents a €10 million...

News

Chemours Names Denise Dignam Permanent CEO

27.03.2024 -

US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of...

News

Celanese and Secarna Collaborate on Long-Acting Antisense Therapies

27.03.2024 -

US chemical group Celanese and Germany’s Secarna Pharmaceuticals, an antisense drug discovery and development company, entered a research collaboration for the...

News

Sandoz Opens Antibiotic Production Facility in Austria

26.03.2024 -

Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving...

News

Dow to Build World-Scale Carbonate Solvents Facility on US Gulf Coast

26.03.2024 -

Dow announced its intent to build a world-scale carbonate solvents production facility for lithium-ion battery production on the US Gulf Coast. The plant will serve...

News

Novo Nordisk to Acquire Cardior Pharmaceuticals

25.03.2024 -

Novo Nordisk is to acquire Cardior Pharmaceuticals for up to €1.025 billion Euros, including an upfront payment and additional payments if certain development and...

News

Johnson Matthey to Sell its Medical Device Components Business

25.03.2024 -

UK’s Johnson Matthey (JM) has signed a definitive agreement to sell 100% of its Medical Device Components (MDC) business to Montagu Private Equity for $700 million (£550...